Lung disease is on the rise, but advancements in diagnostic tools and treatments offer hope for a better future. In a recent Q&A with Medical Device + Diagnostic Industry (MD+DI), Sri Radhakrishnan, Chief Technical Officer at Pulmonx and Narinder Singh Shargill, PhD, Vice President of Global Medical Affairs at Pulmonx, share their insights on how enhanced diagnostic technologies are shaping the next chapter of lung care — from earlier detection to more effective, minimally invasive treatments. Read the full article: https://lnkd.in/egAFcw_W #LungHealth #MedicalTechnology #Pulmonx
Pulmonx Corporation
医疗设备制造业
Redwood City，CA 18,159 位关注者
Improving Breathing and Quality of Life for Emphysema and Advanced COPD Patients
关于我们
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1 1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC Brief Statement: The Pulmonx Zephyr? Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.
- 网站
-
https://www.Pulmonx.com
Pulmonx Corporation的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 201-500 人
- 总部
- Redwood City，CA
- 类型
- 私人持股
- 领域
- Medical Device、Interventional Pulmonology、Emphysema Treatment和Endobronchial Valve Therapy
地点
Pulmonx Corporation员工
动态
-
March is here, and that means Pulmonary Rehabilitation Week is just around the corner! We’re grateful for the incredible advancements in lung health and the dedicated pulmonologists and respiratory therapists who work tirelessly to support those with #COPD and #Emphysema. We’re honored to be part of this incredible community and are grateful to witness the positive impact our Zephyr valves have had on those needing treatment?for severe emphysema/COPD. Explore more about us and the treatment behind it here: bit.ly/4jCRq7d
-
Explore a treatment option for your patients diagnosed with severe COPD/Emphysema, offering them the chance to breathe easier and live better. The Zephyr Valve has been proven to deliver significant health improvements, providing clinical benefits and enhancing quality of life beyond what medication alone can achieve. See Important Safety Information: https://lnkd.in/gTBma6Aw Learn more about our product here: https://bit.ly/4kvN1Dy
-
-
Congratulations to Dr. Jay Kumar and staff at Tampa General Hospital, Brooksville in Florida for launching their Zephyr Valve program and treating their 25th patient with the Zephyr Valves! The Zephyr Valves are a less-invasive treatment option for severe #COPD / #emphysema. ? Pulmonx celebrates key treatment milestones for its customers. For all treating centers in Florida, visit https://lnkd.in/gFjicpBS. For more information on the Zephyr Valves visit https://www.pulmonx.com/?
-
-
Lung cancer screening programs are expanding across the US and Europe, driving earlier detection and improving survival rates. But the impact goes beyond cancer—these scans often reveal other critical findings, like emphysema. Many patients with emphysema—and their physicians—may not realize that additional treatment options are available. Identifying these patients early opens the door to life-changing interventions. As highlighted in this article, there’s a growing opportunity for hospitals to implement clinical pathways for patients with clinically significant emphysema. One approach is leveraging advanced tools like our LungTrax Detect system to support early identification and streamlined care. Let’s shift the focus beyond a single disease state—because improving overall lung health starts with early detection and proactive care. https://lnkd.in/eSVsUnV3
-
A single-center retrospective study of 1400+ patients (over 10 years) showed that undergoing bronchoscopic lung volume reduction (BLVR) may lengthen the usual shortened life expectancy of patients with chronic obstructive pulmonary disease (COPD) and severe lung hyperinflation. Learn more: https://lnkd.in/ey5pMNsX #LungHealth #Lung #COPDAwareness #Pulmonary #Respiratory #Pulmonology Please note this is a non-Pulmonx link, and Pulmonx is not responsible for the content.
-
Próxima parada de la gira en camión de SEPAR: ?anunciada! ??? La gira en camión de SEPAR del "A?o de la Neumología Intervencionista" continúa su recorrido: ??Dónde? ?? Sociedad Castellano Manchega de Patología Respiratoria (SOCAMPAR) – Talavera de la Reina, Toledo.? ??Cuándo? ?? 28 de febrero - 1 de marzo. ?únete a nosotros para tener la oportunidad de aprender de la mano del Dr. Enrique Cases,? experto en Neumología Intervencionista.? Con a?os de experiencia y conocido por su trabajo en reducción del volumen pulmonar mediante broncoscopia (BLVR), el Dr. Cases lo guiará a través de las técnicas que utilizan las válvulas Zephyr, ofreciendo información valiosa y habilidades prácticas que pueden mejorar su experiencia en el tratamiento de pacientes con EPOC/enfisema grave. Esta formación aplicada te dará las herramientas y el conocimiento para aplicar nuevas técnicas en tu prática diaria, mientras? conectas con otros? profesionales y avanzas en tu carrera en Neumología. ?? Obtén más información y planifica tu visita: https://lnkd.in/d9MNCTKW #BLVR #ZephyrValve #SEPARBusTour #EPOC Enrique Cases Viedma Sociedad Espa?ola de Neumología y Cirugía Torácica (SEPAR)
-
Endobronchial valves require evaluation by a specialist trained on EBV to determine patient eligibility. If you have patients struggling despite maximum medical therapy, consider referring your patients to the nearest Zephyr Valve treating doctor for evaluation:? https://bit.ly/4go1caF #Pulmonologist #LungHealth #EndobronchialValve #MedTech #Physicians #Respiratory
-
-
Reducing hyperinflation with endobronchial valves significantly improved cardiac function in patients with severe #COPD/ #emphysema without a history of cardiovascular disease. Read the recent single-center, non-randomized, prospective study of 24 patients. Study Summary: https://bit.ly/3ESBsTD Important Safety Information: https://lnkd.in/gTBma6Aw #EndobronchialValves #Bronchoscopy #MedDevice #Pulmonology
-
-
Bruce was struggling with severe COPD/Emphysema when his doctor suggested he be evaluated for treatment with Zephyr Valves. See how it changed his life. https://bit.ly/4hmzXhZ Results may vary.